ID
16026
Description
Documentation part: Medical conditions & Lab A Randomised, Observer-blind, Multicentre, Non-inferiority, Comparative, Phase III Study of the Safety and Efficacy of Topical 1% SB-275833 Ointment, Applied Twice Daily for 5 Days, versus Topical 2% Sodium Fusidate Ointment Applied Three Times Daily for 7 Days in the Treatment of Adult and Paediatric Subjects with Impetigo. ClinicalTrials.gov Identifier: NCT00133874 Other Study ID Numbers: TOC100224 Responsible Party: GlaxoSmithKline
Keywords
Versions (1)
- 6/26/16 6/26/16 -
Uploaded on
June 26, 2016
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Medical conditions & Lab Topical SB-275833 Ointment 1% For The Treatment Of Impetigo NCT00133874
Medical conditions & Lab Topical SB-275833 Ointment 1% For The Treatment Of Impetigo NCT00133874
Description
Electronically transferred Lab Data
Description
Date sample taken
Data type
date
Measurement units
- DDMONYYYY
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C0200345
Description
Not done
Data type
boolean
Alias
- UMLS CUI [1]
- C1272696
Description
Haem Lab type code
Data type
text
Alias
- UMLS CUI [1,1]
- C0018941
- UMLS CUI [1,2]
- C0805701
Description
Chem Lab type code
Data type
text
Alias
- UMLS CUI [1,1]
- C0005774
- UMLS CUI [1,2]
- C0805701
Description
Urin Lab type code
Data type
text
Alias
- UMLS CUI [1,1]
- C0042014
- UMLS CUI [1,2]
- C0805701
Similar models
Medical conditions & Lab Topical SB-275833 Ointment 1% For The Treatment Of Impetigo NCT00133874
C0022658 (UMLS CUI [2])
C0851341 (UMLS CUI [2])
C0200345 (UMLS CUI [1,2])
C0805701 (UMLS CUI [1,2])
C0805701 (UMLS CUI [1,2])
C0805701 (UMLS CUI [1,2])